Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | Aptinyx Inc (APTX) | OOTC | US | 2022-12-31 | 1 year ago | USD | 0.09 | 0.00 | 0.00% | 0.53 | 584.28% | Ungraded | 0.00 | 0.00% |
| 132 | Alimera Sciences Inc (ALIM) | XNAS | US | 2023-12-31 | 9 months ago | USD | 5.55 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 133 | Ambow Education Holding Ltd (AMBO) | XASE | US | 2024-12-31 | 1 day ago | USD | 2.51 | 0.00 | 0.00% | 0.36 | 14.17% | NCAV (Net-Net) | 0.36 | 14.17% |
| 134 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 1 year ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 135 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 1 day ago | USD | 4.92 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 136 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2024-12-31 | 1 day ago | USD | 1.45 | 0.00 | 0.00% | 0.57 | 39.12% | Ungraded | 0.00 | 0.00% |
| 137 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 1 year ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 138 | Acacia Research Corp (ACTG) | XNAS | US | 2024-12-31 | 1 day ago | USD | 3.74 | 0.00 | 0.00% | 1.86 | 49.71% | Ungraded | 0.00 | 0.00% |
| 139 | Aspen Aerogels Inc (ASPN) | XNYS | US | 2024-12-31 | 1 day ago | USD | 6.34 | 0.00 | 0.00% | 1.57 | 24.80% | Ungraded | 0.00 | 0.00% |
| 140 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 1 day ago | USD | 0.24 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |